Milena I. Ivanova

Sofia, Bulgaria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Characterisation of a Novel HLA-DQA1 Allele by Next Generation Sequencing: HLA-DQA1*01:03:13.

Characterisation of a Novel HLA-DQA1 Allele by Next Generation Sequencing: HLA-DQA1*01:03:13.

Journal: HLA

Published: August 01, 2026

Breast Implant Illness and Autoimmune/Inflammatory Syndrome Induced by Adjuvants: Mechanistic Rationale and a Practical Multidisciplinary Diagnostic Algorithm.

Breast Implant Illness and Autoimmune/Inflammatory Syndrome Induced by Adjuvants: Mechanistic Rationale and a Practical Multidisciplinary Diagnostic Algorithm.

Journal: Journal of clinical medicine

Published: June 27, 2026

Inhibitory HLA-C/KIR2DL2 Interactions and KIR Allelic Polymorphisms Are Associated With Susceptibility to Philadelphia Chromosome-Negative Myeloproliferative Neoplasms.

Inhibitory HLA-C/KIR2DL2 Interactions and KIR Allelic Polymorphisms Are Associated With Susceptibility to Philadelphia Chromosome-Negative Myeloproliferative Neoplasms.

Journal: EJHaem

Published: June 06, 2026

Immunogenetic and Transcriptomic Evidence Implicating the NKG2D-MICA/MICB Axis in CALR-Mutated Myeloproliferative Neoplasms.

Immunogenetic and Transcriptomic Evidence Implicating the NKG2D-MICA/MICB Axis in CALR-Mutated Myeloproliferative Neoplasms.

Journal: Cancers

Published: April 26, 2026

Characterisation of the Novel KIR2DL3*038 Allele by Next Generation Sequencing.

Characterisation of the Novel KIR2DL3*038 Allele by Next Generation Sequencing.

Journal: HLA

Published: June 09, 2025

Characterisation of novel MICB alleles by next generation sequencing: MICB055 and MICB005:15.

Characterisation of novel MICB alleles by next generation sequencing: MICB055 and MICB005:15.

Journal: HLA

Published: June 09, 2024

Characterisation of the novel MICA*112:02 allele by next generation sequencing.

Characterisation of the novel MICA*112:02 allele by next generation sequencing.

Journal: HLA

Published: June 06, 2024

Differential modulation of mutant CALR and JAK2 V617F-driven oncogenesis by HLA genotype in myeloproliferative neoplasms.

Differential modulation of mutant CALR and JAK2 V617F-driven oncogenesis by HLA genotype in myeloproliferative neoplasms.

Journal: Frontiers in immunology

Published: May 08, 2024

Systematic analysis of copper, zinc, and selenium levels in JAK2 V617F-positive myeloproliferative neoplasms.

Systematic analysis of copper, zinc, and selenium levels in JAK2 V617F-positive myeloproliferative neoplasms.

Journal: Annals of hematology

Published: November 20, 2023

Possible impact of HLA class I and class II on malignancies driven by a single germ-line BRCA1 mutation.

Possible impact of HLA class I and class II on malignancies driven by a single germ-line BRCA1 mutation.

Journal: International journal of immunogenetics

Published: May 09, 2023

The role of non-classical and chain-related human leukocyte antigen polymorphisms in laryngeal squamous cell carcinoma.

The role of non-classical and chain-related human leukocyte antigen polymorphisms in laryngeal squamous cell carcinoma.

Journal: Molecular biology reports

Published: March 27, 2023

Exploration of the role of NKG2D ligands MICA and MICB in JAK2 V617F-positive myeloproliferative neoplasms.

Exploration of the role of NKG2D ligands MICA and MICB in JAK2 V617F-positive myeloproliferative neoplasms.

Journal: HLA

Published: June 20, 2022

Showing 1-12 of 39

Last Updated: 09/26/2026